Brief: Neurovive Pharmaceutical Q4 Pre-Tax Loss Widens To SEK 14.8 Mln

Abliva AB

20/02/2018 07:30

Feb 20 (Reuters) - Neurovive Pharmaceutical Ab  NVP.ST : 
    * Q4 NET REVENUE SEK 0 VERSUS SEK 14,000 YEAR AGO 
    * Q4 PRE-TAX LOSS SEK 14.8 MILLION VERSUS LOSS SEK 14.6 
MILLION 
YEAR AGO 
 
Source text for Eikon:  ID:nWkr8whRTZ  
Further company coverage:  NVP.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))